Abstract
Many early studies of injecting drug users (IDUs) suggested that most HIV infections in this population were due to needle sharing and that sexual transmission was negligible or was overshadowed by parenteral routes. A few of the early studies suggested a potentially important role for heterosexual transmission, but these tended to be limited to cross-sectional data or had only a few years of prospective follow-up. Studies of sexual risk factors for HIV infection among non-injecting drug users (NIDUs) are similarly sparse. Recently, investigators prospectively examined both drug-related and sexual risk factors for HIV seroconversion among male and female IDUs with an adequate number of person-years to identify statistically significant associations. Other studies among never and former IDUs have identified associations suggesting that sexual transmission accounts for a substantial number of HIV seroconversions in these populations. Herein, highlights are discussed from recent investigations among IDUs in Baltimore, Maryland, and corroborating findings from the literature. Results from a 10-year prospective analysis of the ALIVE study and an analysis of the REACH studies spanning a 7-year period indicate that sexual risk factors for HIV infection are important in both female and male IDUs. These findings underscore the need for HIV interventions among drug users that incorporate sexual risk reduction. Based on the existing literature, a narrow focus on injection-related risks is an ineffective prevention strategy. Interventions that target specific subgroups of high-risk IDUs, such as men who have sex with men and inject drugs (MSM-IDUs), sex worker-IDUs and HIV-infected IDUs, deserve special attention.
Similar content being viewed by others
References
Des Jarlais DC, Friedman SR, Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med. 1985;103:755–759.
Chaisson RE, Moss AR, Onishi R, et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987;77;169–172.
Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874–879.
Van Ameijden EJC, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12:625–633.
Marx R, Aral SO, Rolfs RT, et al. Crack, sex, and STDs. Sex Transm Dis. 1991;18(2): 92–101.
Battjes RJ, Pickens RW, Amsel Z, et al. Heterosexual transmission of human immunodeficiency virus among intravenous drug users, J Infect Dis. 1990;162(5):1007–1011.
Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behavior for HIV among injecting drug users: a quasi-randomized trial. Lancet. 1999; 353(9165):1657–1661.
Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computerassisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152(2):99–106.
Macalino GE, Celentano DD, Latkin C, et al. Risk’ behaviors by audio computerassisted self-interviews among HIV-seropositive and HIV-seronegative injecting drug users. AIDS Educ Prev. 2002;14(5):367–378.
Doherty MC, Garfein RS, Monterroso E, et al. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717–726.
Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8:437–445.
Tortu S, Beardsley M, Deren S, et al. The risk of HIV infection in a national sample of women with injection drug-using partners. Am J Public Health. 1994;84(8):1243–1249.
Kral A, Bluthenthal R, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;(357):9266:1397–1401.
Strathdee SA, Galai N, Safoiean M. Gender differences in risk factors for HIV seroconversion among injection drug users: a ten-year perspective. Arch Int Med. 2001;161:1281–1288.
Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues. 1991;21:759–776.
Strathdee SA, Safaeian M, Doherty M, et al. Correlates of HIV infection among young new initiates to injection drug use in Baltimore, Maryland: 1994–2000. XIV International Conference on AIDS, Barcelona Spain, July 2002, Abstract number: WePeD6366.
Page-Shafer KA, Hahn JA, Lum P, et al. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr. 2002;31:422–431.
Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med. 1995;155:1305–1311.
Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002;166(7):894–899.
Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon I, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81(10):1291–1295.
Strathdee SA, Patrick DM, Archibald CP, et al. Social determinants predict needle sharing behavior among injection drug users in Vancouver, Canada. Addiction. 1997; 92(10):1291–1295.
Bluthenthal RN, Kral AH, Gee L, et al. Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr. 2001;28(3):264–269.
Shoptaw S, Reback CJ, Freese TE. Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J Addict Dis. 2002;21(1):91–105.
Neaigus A, Miller M, Friedman, et al. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J Inf Dis. 2001;184(3):359–363.
Gyarmathy VA, Neaigus A, Miller M, et al. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr. 2002;30(4):448–456.
Poulin C, Alary M, Bernier F, et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among at-risk women, young sex workers, and street youth attending community organizations in Quebec City, Canada. Sex Transm Dis. 2001;28(8):437–443.
Latkin CA, Mandell W, Knowlton AR, et al. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev. 1998; 10:257–263.
Miller M, Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care. 2002;14(6):801–813.
Walden, Vivien Margaret, Mwangulube Kondwani, et al. Measuring the impact of a behavior change intervention for commercial sex workers and their potential clients in Malawi. Health Educ Res. 1999;14(4):545–554.
MAP (Monitoring the AIDS Pandemic) Symposium Report: The status and trends of the HIV/AIDS epidemic in the world. XIV International AIDS Conference; Barcelona; July 2–4, 2002.
Strathdee SA. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int J Drug Policy. 2003;14:79–81.
Saidel TJ, Des Jarlais D, Peerapatanapokin W, et al. Potential impact of HIV among injection drug users on heterosexual transmission in Asian settings: the Asian epidemic model. Int J Drug Policy. In press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strathdee, S.A., Sherman, S.G. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 80 (Suppl 3), iii7–iii14 (2003). https://doi.org/10.1093/jurban/jtg078
Issue Date:
DOI: https://doi.org/10.1093/jurban/jtg078